Prof. Tufan Bilgin is a gynecologic oncologist with specialized training and extensive clinical experience. He completed his Board of Medical Specialization in Gynecologic Oncology Surgery in 2011 and has been part of the Acibadem Health Group since 2006. Prof. Bilgin is an active member of several professional societies, including the Cervical Pathologies and Colposcopy Society, the International Gynecologic Cancer Society, the European Society of Gynecologic Oncology, the Turkish Society of Gynecologic Oncology, and the Turkish Gynecology and Obstetrics Society. He is dedicated to advancing care for patients with gynecologic cancers through clinical practice, multidisciplinary collaboration, and ongoing engagement with international and national professional communities.
Education
- 2011 Board of Medical Specialization Gynecologic Oncology Surgery
- 2000 Department of Obstetrics and Gynecology, Uludag University Faculty of Medicine / Professor
- 1994 Uludag University Faculty of Medicine, Department of Obstetrics and Gynecology / Associate Professor
- 1992 Uludag University Faculty of Medicine, Department of Obstetrics and Gynecology / Assistant Professor
- 1988 Hacettepe University Faculty of Medicine Gynecology and Obstetrics
- 1982 Hacettepe University Faculty of Medicine
Experience
- 1990 – 2011 Department of Obstetrics and Gynecology, Uludag University Faculty of Medicine
- 2006 Acibadem Health Group
- 1990 Bursa Zübeyde Hanım Maternity Hospital
- 1988 – 1990 Izmir Mevkii Hospital
- 1984 – 1988 Hacettepe University Faculty of Medicine
- 1982 – 1984 Bursa Pilot Region Dispensary
Memberships
- Cervical Pathologies and Colposcopy Society
- International Gynecologic Cancer Society
- European Society of Gynecologic Oncology
- Turkish Society of Gynecologic Oncology
- Turkish Gynecology and Obstetrics Society
Publications
- Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia.
J Obstet Gynaecol Res 30: 205-209, 2004 T.Bilgin, S.Ozuysal, H.Ozan, T.Atakan. - Primary transitional cell carcinoma of the ovary.
Bursa State Hospital Bulletin 19: 47-49, 2004 H.Öztürk, S.Özuysal, T.Bilgin. - Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
Arch Gynecol Obstet 269:159-160, 2004 T.Bilgin, H.Ozan, S.Ozuysal, L.Ozkan. - Bilateral tubaovarian actinomycosis.
Bursa State Hospital Bulletin 19: 35-37, 2004 H.Öztürk, S.Özuysal, T.Bilgin. - Results of cisplatin, adriamycin, etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer.
Eur J Gynaecol Oncol 25: 379-380, 2004 T.Bilgin, H.Ozan, H.F.Kara. - Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia.
J Obstet Gynaecol Res 30: 205-209, 2004 T.Bilgin, S.Ozuysal, T.Atakan, H.Ozan. - In which cases and in which limitations should conservative surgery be performed in ovarian cancer in reproductive age?
Turkish Society of Gynecology and Obstetrics Journal of Post Specialty Education 7: 108-112, 2004 T. Bilgin. - Results of cisplatin, adriamycin, etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer.
Eur J Gynaecol Oncol 25: 379-380, 2004 T.Bilgin, H.Ozan, H.F.Kara - Ovarian endodermal sinus tumor in a 76-year-old woman.
J Obstet Gynaecol Res 29: 309-311, 2003 G.Filiz, S.Ozuysal, T.Bilgin.
